Yan Interviewed by Nature Outlooks

Hai Yan, PhD

Hai Yan, PhD was interviewed by Nature Outlooks  to give his perspective on glioma genetics and its implications in clinical practice.  This supplement to Nature  tackles topics of scientific, clinical and societal interest, giving a comprehensive picture of the current state of knowledge and the hottest areas of research. Dr. Yan is noted for his seminal discoveries of IDH1/2, ATRX, Smarcal1, and TERT mutations, which form the basis for the WHO classification of gliomas, and provide more accurate diagnostic and prognostic information, enabling personalized therapy and tailored clinical trials.